MorphoSys AG Strengthens Clinical Development Organization With Three Management Appointments
12/19/2013 9:24:17 AM
MARTINSRIED / MUNICH, Germany, Dec. 19, 2013 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has completed the expansion of its senior clinical development team by appointing Dr. Gabriele Elbl as Head of Regulatory Affairs, Dr. Ludger Langer as Head of Clinical Operations and Project Management and most recently Dr. Steffen Heeger as Head of Clinical Research.
Help employers find you! Check out all the jobs and post your resume.
comments powered by